HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,855: | Line 1,855: | ||
| | | | ||
|- | |- | ||
|Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say | |Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say "This page was converted to the new template on 2023-12-07. The original page can be found at [[HAEM4:Polymorphic Post-Transplant Lymphoproliferative Disorders]]. | ||
Note: encompassing polymorphic PTLD, other iatrogenic immunodef-assoc lympho disorders, among others) | Note: encompassing polymorphic PTLD, other iatrogenic immunodef-assoc lympho disorders, among others)" | ||
| || || || ||GC|| || | | || || || ||GC|| || | ||
|Polymorphic Post-Transplant Lymphoproliferative Disorders | |Polymorphic Post-Transplant Lymphoproliferative Disorders | ||
| Line 1,865: | Line 1,865: | ||
|- | |- | ||
|EBV-positive mucocutaneous ulcer||Disease|| || || || || ||GC|| || | |EBV-positive mucocutaneous ulcer||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Lymphomas arising in immune deficiency / dysregulation||Disease|| || || || || ||GC|| || | |Lymphomas arising in immune deficiency / dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say "encompassing monomorphic PTLD, classic HL PTLD, lymphomas assoc with HIV infection, among others"|| || || || ||GC|| || | ||
| | | | ||
| | | | ||
| Line 1,878: | Line 1,878: | ||
| | | | ||
|- | |- | ||
|Inborn error of immunity-associated lymphoid proliferations and lymphomas||Disease|| || || || || ||GC|| || | |Inborn error of immunity-associated lymphoid proliferations and lymphomas||Disease||FIX ISSUE! (on 5th edition page instructions say "Editor said this overview page is a match. [Immunodeficiency-Associated Lymphoproliferative Disorders] [Lymphoproliferative diseases associated with primary immune disorders]")|| || || || ||GC|| || | ||
| | | | ||
| | | | ||
| Line 1,885: | Line 1,885: | ||
| | | | ||
|- | |- | ||
|Classic Hodgkin lymphoma||Disease|| || || || || | |Classic Hodgkin lymphoma||Disease|| || || || ||Note: author needs to merge Nodular Sclerosis Classic Hodgkin Lymphoma, Lymphocyte-Rich Classic Hodgkin Lymphoma, Mixed Cellularity Classic Hodgkin Lymphoma, Lymphocyte-Depleted Classic Hodgkin Lymphoma | ||
| | |GC|| || | ||
|Patricia V. Hernandez, M.D., Washington University School of Medicine | |(1) Lymphocyte-Rich Classic Hodgkin Lymphoma + (2) Nodular Sclerosis Classic Hodgkin Lymphoma + (3) Mixed Cellularity Classic Hodgkin Lymphoma + (4) Lymphocyte-Depleted Classic Hodgkin Lymphoma | ||
| | |(1) Patricia V. Hernandez, M.D., Washington University School of Medicine and Holli Drendel + (2) Xiaolin Hu, PhD, Sema4 OpCo Inc. + (3 and 4) Patricia V. Hernandez | ||
| | |Pending + Completed (03/21/22) | ||
|Not completed for checking (1, 3 and 4) + 03/21/22 (2) | |||
| | | | ||
|- | |- | ||